Answers are grounded in this paper and cite their sources.
Uterotibb is one of the potent Unani medicines that offers a natural solution to various human health issues. The present investigation explores the active phytochemical constituents of Unani medicine Uterotibb using GC-MS analysis. This study further evaluated the antioxidant potential and antimicrobial activity against a panel of human pathogens such as Staphylococcus aureus, Bacillus Subtilis, E. coli, and Klebsiella pneumonia. GC-MS studies revealed the presence of 388 phytochemical compounds in the alkali aqueous extract of Uterotibb. The main active biomolecules were stigmast-5– en-3-0l, and oleate (2.84%). Cyclotrisiloxane, hexamethyl (1.74%). 1,2,5-oxadiazole-3-carboxamide4-amino-N-(2-methoxyethyl)-(1.75%). Arsenous acid (1.48%). Pentane,1,1-thiobis (1.46%). 7,7,9,9,11,11-hexamethyl-3,6,8,10,12,15hexaoxa-7,9,11-trisilaheptadecane (1.46%). 4-(1,1dimethylpropyl-phenol, trimethylsilyl ether (1.43%). 1,2-bis (trimethyl silyl) benzene (1.36%). Adamantane methyl amine (1.32%). 1,4-benzenediole,2,5-bis(1,1 dimethyl ethyl)-(1.29%). 2-chloro aniline-5-sulphonic acid (1.28%); Acetic Acid, nitro-, methyl ester (1.24%) and Caprolactone oxime, (NB)-O-[(diethylboryloxy) (ethyl)boryl] (1.21%). Notably, Uterotibb extract exhibited antimicrobial activity in a concentration-dependent manner, where the highest concentration of 5 mg/mL showed a maximum zone of growth inhibition of 14.95±0.35 mm against Staphylococcus aureus, and the lowest zone of inhibition was 13.26±0.88 mm against Bacillus subtilis at the same concentration. The lowest MIC value was exhibited at 2 mg/mL concentration against Staphylococcus aureus where the highest MIC value of 4 mg/mL was observed against K. Pneumoniae. Further, the antioxidant potential of the extract exhibited scavenging activity of 67.115 ± 0.05 and 73.67 ± 0.09 using DPPH and ABTS assays, respectively. Finally, GC-MS profiling and bioactivity studies of the present work validate Uterotibb's potential as a natural Unani medicine for human care.
No takes yet. Share an insight, caveat, or question.
Aziz et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: